PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
23-Sep-2021 Rising Covid deaths and falling antibodies will force Plan C, says expert London Medical Laboratory
23-Sep-2021 CPhI Report predicts record EBITDAs for CDMOs in 2022 CPhI Worldwide
23-Sep-2021 Erythromycin Market To Be Worth UЅD $8,194.9 Мn By 2030: MarketResearch.Biz MarketResearch.Biz
23-Sep-2021 Multiple myeloma - high quality of life possible thanks to new therapies GSK
23-Sep-2021 FDA APPROVES ABBOTT'S EPIC™ PLUS TISSUE VALVES FOR PEOPLE IN NEED OF MITRAL OR AORTIC VALVE REPLACEMENT Abbott
23-Sep-2021 LIMBIC RECEIVES UKCA CERTIFICATION LIMBIC
22-Sep-2021 GSK receives CHMP positive opinions recommending approval of Nucala (mepolizumab) in three additional eosinophil-driven diseases GSK
22-Sep-2021 BRITS IGNORE THEIR EYE HEALTH AND MISS OUT ON ESSENTIAL EYE TESTS Théa
22-Sep-2021 Changing attitudes to vaccination after the COVID-19 pandemic could increase adult vaccination rates, improving health outcomes over the longer term GSK
22-Sep-2021 NHS encourages people to get COVID booster jab as bookings open NHS England
22-Sep-2021 New NHS clinical leadership to support post-COVID challenges NHS England
22-Sep-2021 Kepler Vision expands care of dementia patients into the hallways Kepler Vision
22-Sep-2021 Think tank calls for greater focus on vaccinating at-risk groups ahead of this year’s winter flu season Think tank
22-Sep-2021 Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS) Celltrion Group
21-Sep-2021 NEW INDOOR GARDEN OPENS AT CHELSEA AND WESTMINSTER HOSPITAL CW+
21-Sep-2021 Theramex launches Bijuva® / Bijuve® (estradiol and progesterone), the first and only body-identical combined hormone therapy treatment for post-menopausal women* Theramex
21-Sep-2021 GSK announces major renewable energy investment and low carbon inhaler programme alongside Life Sciences sector Race to Zero ‘breakthrough’ at NYC Climate Week GSK
21-Sep-2021 ABBOTT RECEIVES FDA APPROVAL FOR MINIMALLY INVASIVE PORTICO™ WITH FLEXNAV™ TAVR SYSTEM TO TREAT PATIENTS WITH AORTIC VALVE DISEASE ABBOTT
21-Sep-2021 NHS encourages people to get COVID booster jab as bookings open NHS England
21-Sep-2021 Emmes Standardizes on Veeva Development Cloud to Streamline Product Development Emmes